Optical Preclinical Imaging Market
Optical Preclinical Imaging Market Analysis by Bioluminescent Imaging Reagents and Fluorescent Imaging Reagents for Research & Development and Drug Discovery from 2023 to 2033
Analysis of Optical Preclinical Imaging Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Optical Preclinical Imaging Market Outlook (2023 to 2033)
The global optical preclinical imaging market is valued at US$ 612 million in 2023 and is projected to reach US$ 1.14 billion by 2033. Global demand for optical preclinical imaging systems is expected to increase at a CAGR of 6.5% during the next 10 years.
Preclinical imaging involves the visualization of living creatures for scientific purposes, primarily for drug development. Additionally, this technology enables in-vivo molecular imaging for the diagnosis and treatment of illnesses. It serves as a link between in-vitro and in-vivo clinical drug development studies.
Fluorescence, bioluminescence, single-photon emission computed tomography (SPECT), and positron emission tomography (PET) is employed for molecular structure visualization in optical imaging techniques.
Preclinical imaging has been a crucial technique for biological advancements over the past ten years. In the post-genomic era, high-frequency micro-ultrasound has gradually evolved into a quick and affordable imaging technique for researching human disease models in microscopic organisms.
The demand for preclinical optical imaging technologies is expanding primarily as a result of increasing investments and funding for medical R&D activities as well as the rapid pace of technological developments that have led to the development of hybrid imaging systems.
Preclinical optical imaging devices are segmented into bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, and optical + X-ray/optical + CT systems. Sales of bioluminescence & fluorescence imaging systems are predicted to rise at a CAGR of 7.5% from 2023 to 2033.
Bioluminescence imaging and fluorescence imaging is a vital research method for understanding biological mechanisms in-vivo and in real time. One of the main benefits of bioluminescence imaging is its low signal-to-noise ratio (SNR), high sensitivity, and capacity to examine processes in-vivo without hurting the target animal.
Bioluminescence imaging provides a dependable, sensitive, and high throughput alternative to more traditional imaging and biodistribution studies using terminal endpoints, invasive techniques, or radiolabeling. For non-invasive in-vivo molecular imaging, optical imaging, in particular near-infrared fluorescence (NIRF) imaging, offers a brand-new and incredibly flexible platform for drug discovery and research.
Optical fluorescence imaging offers 3D, real-time image augmentation and cellular and subcellular resolutions. One of the important technologies that can advance molecular imaging is fluorescence imaging. It is also very useful in preclinical research and has contributed to recent developments in oncology, genetics, and proteomics. Thus, several technological advancements are boosting the demand for optical imaging systems.
| Report Attributes | Details |
|---|---|
| Optical Preclinical Imaging Market Size (2023E) | US$ 612 Million |
| Forecasted Market Value (2033F) | US$ 1.14 Billion |
| Global Market Growth Rate (2023 to 2033) | 6.5% CAGR |
| China Market Growth Rate (2023 to 2033) | 10% CAGR |
| Japan Market Growth Rate (2023 to 2033) | 3.5% CAGR |
| Germany Market Growth Rate (2023 to 2033) | 4% CAGR |
| Canada Market Growth Rate (2023 to 2033) | 4.5% CAGR |
| Key Companies Profiled | BioTek Instruments, Inc.; Bruker Corporation; Fujifilm Holdings Corporation; Magnetic Insight, Inc.; MBF Bioscience; Mediso Ltd.; MILabs B.V.; Miltenyi Biotec; MR Solutions; PerkinElmer, Inc.; TriFoil Imaging; Vieworks Co., Ltd. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How is Demand for Optical Preclinical Imaging Systems Evolving across the World?
“High Adoption of In-vivo Imaging Technologies”
The utilization of in-vivo imaging techniques in preclinical studies is growing due to the rising rate of clinical research organizations (CROs) and pharmaceutical companies. Thus, this factor is further anticipated to accelerate the growth of the optical preclinical imaging market.
- To build its first sizable preclinical imaging suite, the USF Health Morsani College of Medicine purchased new 7T-3T MR/PET & PET-CT devices by MR solutions in July 2020.
- To meet the growing need for antiviral research instruments and to facilitate the study of coronavirus antibodies and medicines, MILabs upgraded their preclinical diagnostic U-CT technology for in-vivo imaging of COVID-19 animal-based models in March 2020.
One of the new capabilities is ultra-high-resolution non-invasive lung imaging, which enables scientists to precisely locate pathological changes in the bronchi of guinea pigs, mice, and ferrets. Up to four mouse models can also be examined simultaneously for high-throughput detection of coronavirus genotypes linked to respiratory illness utilizing intrinsic freeze-frame lung imaging.
“Advancements in Multi-modal Molecular Imaging Devices”
Technological improvements in molecular imaging, the rising need for non-invasive imaging techniques on small animals, and rising preclinical research investments from both commercial and public organizations are some of the factors driving the growth of the market for preclinical imaging.
A fast-growing multidiscipline, molecular imaging integrates molecular biology, chemistry, engineering, computer science, and medicine. It is capable of real-time, non-invasive viewing and quantification of physiological or pathological processes occurring at the cellular or molecular level in a living organism.
Multi-modal molecular imaging can play a significant role in the clinical management of several diseases by enhancing doctors' capacity for screening, monitoring, prognosis, staging, planning and therapy advice, measuring therapy efficacy, and recurrence assessment. Presymptomatic detection, targeted therapy, and the development of personalized medicines are also some of the advancements in multi-modal molecular imaging technology.
“Rising Cases of Chronic Disorders”
The need for diagnostic and therapeutic technologies is rising as a result of the exponential rise in the prevalence of chronic disorders such as cancer, respiratory diseases, arthritis, and heart disease. Respective governments of several nations are initiating various programs to increase awareness of early cancer detection to reduce cancer-related fatalities.
- According to a study by the World Cancer Research Fund International, about 18.1 million cases of cancer were reported globally in 2020, of which more than 474,519 cases were of leukaemia, also known as blood cancer.
- The National Programme for Prevention and Control of cancer, cardiovascular diseases, diabetes, and strokes have been announced by the Indian government to increase awareness of early cancer diagnosis.
Which Issues are Hampering the Sales of Optical Preclinical Imaging Devices?
“Strict Rules Regarding Animal Welfare & Preclinical Research”
Strict rules governing preclinical research and laws regarding animal protection are hampering sales growth. Animal activists strongly oppose the use of animals for lab testing, which acts as an obstacle before researchers. Also, the high costs of systems & expensive research projects along with the scarcity of experts may hinder the sales of optical preclinical imaging devices to some extent.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
Why is the United States a leading Market for Optical Preclinical Imaging Solutions?
“Presence of Advanced Healthcare Sector”
The United States currently dominates the North American market due to the significant number of ongoing preclinical studies and greater acceptance rates of technologically advanced equipment.
The presence of a well-established healthcare sector and rising investments by public and private organizations in preclinical research projects is also expected to boost the demand for optical imaging technologies.
The high use of in-vivo imaging systems in preclinical research by clinical research organisations (CROs) and pharmaceutical companies is also boosting sales growth. Several market players are also introducing advanced preclinical imaging solutions.
- A renowned manufacturer of multiphoton microscopes for deep tissue fluorescence imaging, Bruker, announced the launch of the Ultima Investigator Plus in March 2022. This platform is the newest modular entry to the Ultima line. With a wider field of view, improved optics for two- and three-photon imaging, and a longer close-coupled collection path, Investigator Plus improves scientists' ability to image deeply and see more inside difficult specimens.
What is Supporting the Sales of Optical Preclinical Imaging Systems in Germany?
“Rapidly Increasing Prevalence of Cancer”
Germany is a hub for pharma and biotech companies in the European region. The demand for imaging devices is increasing rapidly due to the rising prevalence of chronic disorders such as cancer.
Nowadays, clinical trials often use imaging equipment as a response to research laboratories' efforts to reduce operating costs. Each year, the European Union (EU) approves roughly 4,000 clinical studies for pharmaceuticals.
Most of these trials are conducted in Western European countries including Germany, the Netherlands, France, and Switzerland. As per industry analysis by Fact.MR, a market research and competitive intelligence provider, demand for optical preclinical imaging solutions in Germany is expected to increase at a CAGR of 4% during the next 10 years.
What is the Demand Outlook for Optical Preclinical Imaging Technologies in Japan?
“Rising Cases of Fatty Liver Diseases and Growing Demand for Personalized Medicines”
Asian countries such as Japan, India, China, and South Korea are experiencing rapid market growth due to the development of non-alcoholic steatohepatitis (NASH) drug testing as well as rapidly advancing medical treatments and technologies. NASH is currently estimated to affect 1.9% to 2.7% of the population in Japan.
The prevalence of non-alcoholic fatty liver disease (NAFLD) in the Japanese population has increased since the early 1990s; in the 1990s it went from 12.6% to 12.9% and 24.6% to 34.7% in the 2000s. Demand for preclinical imaging services is also increasing due to the rapidly ageing population, rising cancer and obesity patients, and a fast-growing healthcare sector.
In Japan, customized medicine is becoming a new objective in the diagnosis and treatment of illnesses. It tries to identify differences between patients with the same illness so that they can select the best appropriate treatment.
- The Japanese Journal of Radiology published a paper in November 2021 titled ‘Developing diagnostic reference levels in Japan’ that claimed the country has seen a considerable rise in the utilization of radiological examinations in recent years.
- A report released in February 2021 by the Government of Japan's Public Relations Office predicted that by the years 2036 and 2065, respectively, 33.3% and 38.4% of Japan's population would be over 65.
Category-wise Analysis
Why is There High Demand for Optical Preclinical Imaging Systems From Pharma & Biotech Companies?
“Rising Need for Advanced Drugs Increasing Rate of Clinical Trials”
Demand for optical preclinical imaging systems from pharma and biotech companies is increasing at a rapid pace. Several clinical trials are carried out in pharma and biotech companies for drug discovery and development, which is supporting sales growth.
The growing cases of chronic disorders such as cancer are increasing the healthcare burden. Thus, this aspect is increasing the need for drug innovation which subsequently is boosting the demand for preclinical imaging technologies.
- The International Agency for Research on Cancer (IARC) predicts that by 2030, there would be 21.7 million new cases of cancer annually and 13 million cancer deaths. An older population, a higher prevalence of obesity, and environmental factors are all blamed for this rise. In addition, cancer is more common in women, and breast cancer is the malignancy that kills the most women.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the optical preclinical imaging market are improving their market position by advancing imaging technologies. Regional expansion, partnerships, collaborations with local suppliers, and improving product standards are some of the tactics adopted by leading companies.
- The Vega imaging system has been added to PerkinElmer, Inc. PKI's line of in-vivo imaging products, the company announced in April 2022. This groundbreaking ultrasound platform combines hands-free automated technology with enhanced capacities to provide non-invasive research and drug development studies in the areas of cancer, kidney and liver disorders, cardiology, and other medical specialties.
Key Segments of Optical Preclinical Imaging Industry Research
-
By Modality :
- Bioluminescence/Fluorescence Imaging Systems
- Standalone Fluorescence Imaging Systems
- Optical + X-ray/Optical + CT
-
By Reagent :
- Bioluminescent Imaging Reagents
- Fluorescent Imaging Reagents
-
By Application :
- Research & Development
- Drug Discovery
-
By End User :
- Pharma & Biotech Companies
- Research Institutes
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Pricing Analysis
- 5. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033)
- 6. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Modality
- 6.1. Bioluminescence/Fluorescence Imaging Systems
- 6.2. Standalone Fluorescence Imaging Systems
- 6.3. Optical + X-ray/Optical + CT
- 7. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Reagent
- 7.1. Bioluminescent Imaging Reagents
- 7.2. Fluorescent Imaging Reagents
- 7.3. Market Key Findings, by Reagent
- 8. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Application
- 8.1. Research & Development
- 8.2. Drug Discovery
- 9. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by End User
- 9.1. Pharma & Biotech Companies
- 9.2. Research Institutes
- 10. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Region
- 10.1. North America
- 10.2. Europe
- 10.3. East Asia
- 10.4. South Asia
- 10.5. Latin America
- 10.6. Middle East & Africa (MEA)
- 10.7. Oceania
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia Market Analysis and Forecast
- 15. Latin America Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Oceania Market Analysis and Forecast
- 18. Global Market Analysis Key Countries
- 19. Competition Landscape
- 20. Competition Analysis
- 20.1. BioTek Instruments, Inc.
- 20.2. Bruker Corporation
- 20.3. Fujifilm Holdings Corporation
- 20.4. Magnetic Insight, Inc.
- 20.5. MBF Bioscience
- 20.6. Mediso Ltd.
- 20.7. MILabs B.V.
- 20.8. Miltenyi Biotec
- 20.9. MR Solutions
- 20.10. PerkinElmer, Inc.
- 20.11. TriFoil Imaging
- 20.12. Vieworks Co., Ltd.
- 21. Appendix
- 22. Definitions of Analytical Frameworks
- 23. Sources and References
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units), by Modality, 2018 to 2033
Table 02: Global Market Value (US$ Mn), by Modality, 2018 to 2033
Table 03: Global Market Volume (Units), by Reagent, 2018 to 2033
Table 04: Global Market Value (US$ Mn), by Reagent, 2018 to 2033
Table 05: Global Market Volume (Units), by Application, 2018 to 2033
Table 06: Global Market Value (US$ Mn), by Application, 2018 to 2033
Table 07: Global Market Volume (Units), by End User, 2018 to 2033
Table 08: Global Market Value (US$ Mn), by End User, 2018 to 2033
Table 09: Global Market Volume (Units), by Region, 2018 to 2033
Table 10: Global Market Value (US$ Mn), by Region, 2018 to 2033
Table 11: North America Market Volume (Units), by Modality, 2018 to 2033
Table 12: North America Market Value (US$ Mn), by Modality, 2018 to 2033
Table 13: North America Market Volume (Units), by Reagent, 2018 to 2033
Table 14: North America Market Value (US$ Mn), by Reagent, 2018 to 2033
Table 15: North America Market Volume (Units), by Application, 2018 to 2033
Table 16: North America Market Value (US$ Mn), by Application, 2018 to 2033
Table 17: North America Market Volume (Units), by End User, 2018 to 2033
Table 18: North America Market Value (US$ Mn), by End User, 2018 to 2033
Table 19: North America Market Volume (Units), by Country, 2018 to 2033
Table 20: North America Market Value (US$ Mn), by Country, 2018 to 2033
Table 21: Europe Market Volume (Units), by Modality, 2018 to 2033
Table 22: Europe Market Value (US$ Mn), by Modality, 2018 to 2033
Table 23: Europe Market Volume (Units), by Reagent, 2018 to 2033
Table 24: Europe Market Value (US$ Mn), by Reagent, 2018 to 2033
Table 25: Europe Market Volume (Units), by Application, 2018 to 2033
Table 26: Europe Market Value (US$ Mn), by Application, 2018 to 2033
Table 27: Europe Market Volume (Units), by End User, 2018 to 2033
Table 28: Europe Market Value (US$ Mn), by End User, 2018 to 2033
Table 29: Europe Market Volume (Units), by Country, 2018 to 2033
Table 30: Europe Market Value (US$ Mn), by Country, 2018 to 2033
Table 31: East Asia Market Volume (Units), by Modality, 2018 to 2033
Table 32: East Asia Market Value (US$ Mn), by Modality, 2018 to 2033
Table 33: East Asia Market Volume (Units), by Reagent, 2018 to 2033
Table 34: East Asia Market Value (US$ Mn), by Reagent, 2018 to 2033
Table 35: East Asia Market Volume (Units), by Application, 2018 to 2033
Table 36: East Asia Market Value (US$ Mn), by Application, 2018 to 2033
Table 37: East Asia Market Volume (Units), by End User, 2018 to 2033
Table 38: East Asia Market Value (US$ Mn), by End User, 2018 to 2033
Table 39: East Asia Market Volume (Units), by Country, 2018 to 2033
Table 40: East Asia Market Value (US$ Mn), by Country, 2018 to 2033
Table 41: South Asia Market Volume (Units), by Modality, 2018 to 2033
Table 42: South Asia Market Value (US$ Mn), by Modality, 2018 to 2033
Table 43: South Asia Market Volume (Units), by Reagent, 2018 to 2033
Table 44: South Asia Market Value (US$ Mn), by Reagent, 2018 to 2033
Table 45: South Asia Market Volume (Units), by Application, 2018 to 2033
Table 46: South Asia Market Value (US$ Mn), by Application, 2018 to 2033
Table 47: South Asia Market Volume (Units), by End User, 2018 to 2033
Table 48: South Asia Market Value (US$ Mn), by End User, 2018 to 2033
Table 49: South Asia Market Volume (Units), by Country, 2018 to 2033
Table 50: South Asia Market Value (US$ Mn), by Country, 2018 to 2033
Table 51: Latin America Market Volume (Units), by Modality, 2018 to 2033
Table 52: Latin America Market Value (US$ Mn), by Modality, 2018 to 2033
Table 53: Latin America Market Volume (Units), by Reagent, 2018 to 2033
Table 54: Latin America Market Value (US$ Mn), by Reagent, 2018 to 2033
Table 55: Latin America Market Volume (Units), by Application, 2018 to 2033
Table 56: Latin America Market Value (US$ Mn), by Application, 2018 to 2033
Table 57: Latin America Market Volume (Units), by End User, 2018 to 2033
Table 58: Latin America Market Value (US$ Mn), by End User, 2018 to 2033
Table 59: Latin America Market Volume (Units), by Country, 2018 to 2033
Table 60: Latin America Market Value (US$ Mn), by Country, 2018 to 2033
Table 61: Middle East and Africa Market Volume (Units), by Modality, 2018 to 2033
Table 62: Middle East and Africa Market Value (US$ Mn), by Modality, 2018 to 2033
Table 63: Middle East and Africa Market Volume (Units), by Reagent, 2018 to 2033
Table 64: Middle East and Africa Market Value (US$ Mn), by Reagent, 2018 to 2033
Table 65: Middle East and Africa Market Volume (Units), by Application, 2018 to 2033
Table 66: Middle East and Africa Market Value (US$ Mn), by Application, 2018 to 2033
Table 67: Middle East and Africa Market Volume (Units), by End User, 2018 to 2033
Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2018 to 2033
Table 69: Middle East and Africa Market Volume (Units), by Country, 2018 to 2033
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2018 to 2033
Table 71: Oceania Market Volume (Units), by Modality, 2018 to 2033
Table 72: Oceania Market Value (US$ Mn), by Modality, 2018 to 2033
Table 73: Oceania Market Volume (Units), by Reagent, 2018 to 2033
Table 74: Oceania Market Value (US$ Mn), by Reagent, 2018 to 2033
Table 75: Oceania Market Volume (Units), by Application, 2018 to 2033
Table 76: Oceania Market Value (US$ Mn), by Application, 2018 to 2033
Table 77: Oceania Market Volume (Units), by End User, 2018 to 2033
Table 78: Oceania Market Value (US$ Mn), by End User, 2018 to 2033
Table 79: Oceania Market Volume (Units), by Country, 2018 to 2033
Table 80: Oceania Market Value (US$ Mn), by Country, 2018 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (Units), Value (US$ Thousand) and Y-o-Y Growth, 2018 to 2033
Figure 02: Global Absolute $ Historical Market (2018 to 2022) and Absolute $ Opportunity (2023 to 2033), US$ Mn
Figure 03: Global Absolute Historical Volume Market (2018 to 2022) and Absolute Volume Opportunity (2023 to 2033), Units
Figure 04: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 05: Global Market Incremental $ Opportunity (US$ Thousand), 2023 to 2033
Figure 06: Global Market Share, By Modality – 2023 to 2033
Figure 07: Global Market Y-o-Y Growth Projections, By Modality – 2023 to 2033
Figure 08: Global Market Attractiveness Index, By Modality – 2023 to 2033
Figure 09: Global Market Share, By Reagent – 2023 to 2033
Figure 10: Global Market Y-o-Y Growth Projections, By Reagent – 2023 to 2033
Figure 11: Global Market Attractiveness Index, By Reagent – 2023 to 2033
Figure 12: Global Market Share, By Application – 2023 to 2033
Figure 13: Global Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Figure 14: Global Market Attractiveness Index, By Application – 2023 to 2033
Figure 15: Global Market Share, By End User – 2023 to 2033
Figure 16: Global Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Figure 17: Global Market Attractiveness Index, By End User – 2023 to 2033
Figure 18: Global Market Share, by Region – 2023 to 2033
Figure 19: Global Market Y-o-Y Growth Projections, by Region – 2023 to 2033
Figure 20: Global Market Attractiveness Index, by Region – 2023 to 2033
Figure 21: North America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Figure 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Figure 23: North America Market Share, By Modality – 2023 to 2033
Figure 24: North America Market Y-o-Y Growth Projections, By Modality – 2023 to 2033
Figure 25: North America Market Attractiveness Index, By Modality – 2023 to 2033
Figure 26: North America Market Share, By Reagent – 2023 to 2033
Figure 27: North America Market Y-o-Y Growth Projections, By Reagent – 2023 to 2033
Figure 28: North America Market Attractiveness Index, By Reagent – 2023 to 2033
Figure 29: North America Market Share, By Application – 2023 to 2033
Figure 30: North America Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Figure 31: North America Market Attractiveness Index, By Application – 2023 to 2033
Figure 32: North America Market Share, By End User – 2023 to 2033
Figure 33: North America Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Figure 34: North America Market Attractiveness Index, By End User – 2023 to 2033
Figure 35: North America Market Share, By Country – 2023 to 2033
Figure 36: North America Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Figure 37: North America Market Attractiveness Index, By Country – 2023 to 2033
Figure 38: Europe Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Figure 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Figure 40: Europe Market Share, By Modality – 2023 to 2033
Figure 41: Europe Market Y-o-Y Growth Projections, By Modality – 2023 to 2033
Figure 42: Europe Market Attractiveness Index, By Modality – 2023 to 2033
Figure 43: Europe Market Share, By Reagent – 2023 to 2033
Figure 44: Europe Market Y-o-Y Growth Projections, By Reagent – 2023 to 2033
Figure 45: Europe Market Attractiveness Index, By Reagent – 2023 to 2033
Figure 46: Europe Market Share, By Application – 2023 to 2033
Figure 47: Europe Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Figure 48: Europe Market Attractiveness Index, By Application – 2023 to 2033
Figure 49: Europe Market Share, By End User – 2023 to 2033
Figure 50: Europe Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Figure 51: Europe Market Attractiveness Index, By End User – 2023 to 2033
Figure 52: Europe Market Share, By Country – 2023 to 2033
Figure 53: Europe Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Figure 54: Europe Market Attractiveness Index, By Country – 2023 to 2033
Figure 55: East Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Figure 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Figure 57: East Asia Market Share, By Modality – 2023 to 2033
Figure 58: East Asia Market Y-o-Y Growth Projections, By Modality – 2023 to 2033
Figure 59: East Asia Market Attractiveness Index, By Modality – 2023 to 2033
Figure 60: East Asia Market Share, By Reagent – 2023 to 2033
Figure 61: East Asia Market Y-o-Y Growth Projections, By Reagent – 2023 to 2033
Figure 62: East Asia Market Attractiveness Index, By Reagent – 2023 to 2033
Figure 63: East Asia Market Share, By Application – 2023 to 2033
Figure 64: East Asia Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Figure 65: East Asia Market Attractiveness Index, By Application – 2023 to 2033
Figure 66: East Asia Market Share, By End User – 2023 to 2033
Figure 67: East Asia Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Figure 68: East Asia Market Attractiveness Index, By End User – 2023 to 2033
Figure 69: East Asia Market Share, By Country – 2023 to 2033
Figure 70: East Asia Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Figure 71: East Asia Market Attractiveness Index, By Country – 2023 to 2033
Figure 72: South Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Figure 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Figure 74: South Asia Market Share, By Modality – 2023 to 2033
Figure 75: South Asia Market Y-o-Y Growth Projections, By Modality – 2023 to 2033
Figure 76: South Asia Market Attractiveness Index, By Modality – 2023 to 2033
Figure 77: South Asia Market Share, By Reagent – 2023 to 2033
Figure 78: South Asia Market Y-o-Y Growth Projections, By Reagent – 2023 to 2033
Figure 79: South Asia Market Attractiveness Index, By Reagent – 2023 to 2033
Figure 80: South Asia Market Share, By Application – 2023 to 2033
Figure 81: South Asia Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Figure 82: South Asia Market Attractiveness Index, By Application – 2023 to 2033
Figure 83: South Asia Market Share, By End User – 2023 to 2033
Figure 84: South Asia Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Figure 85: South Asia Market Attractiveness Index, By End User – 2023 to 2033
Figure 86: South Asia Market Share, By Country – 2023 to 2033
Figure 87: South Asia Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Figure 88: South Asia Market Attractiveness Index, By Country – 2023 to 2033
Figure 89: Latin America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Figure 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Figure 91: Latin America Market Share, By Modality – 2023 to 2033
Figure 92: Latin America Market Y-o-Y Growth Projections, By Modality – 2023 to 2033
Figure 93: Latin America Market Attractiveness Index, By Modality – 2023 to 2033
Figure 94: Latin America Market Share, By Reagent – 2023 to 2033
Figure 95: Latin America Market Y-o-Y Growth Projections, By Reagent – 2023 to 2033
Figure 96: Latin America Market Attractiveness Index, By Reagent – 2023 to 2033
Figure 97: Latin America Market Share, By Application – 2023 to 2033
Figure 98: Latin America Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Figure 99: Latin America Market Attractiveness Index, By Application – 2023 to 2033
Figure 100: Latin America Market Share, By End User – 2023 to 2033
Figure 101: Latin America Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Figure 102: Latin America Market Attractiveness Index, By End User – 2023 to 2033
Figure 103: Latin America Market Share, By Country – 2023 to 2033
Figure 104: Latin America Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Figure 105: Latin America Market Attractiveness Index, By Country – 2023 to 2033
Figure 106: MEA Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Figure 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Figure 108: MEA Market Share, By Modality – 2023 to 2033
Figure 109: MEA Market Y-o-Y Growth Projections, By Modality – 2023 to 2033
Figure 110: MEA Market Attractiveness Index, By Modality – 2023 to 2033
Figure 111: MEA Market Share, By Reagent – 2023 to 2033
Figure 112: MEA Market Y-o-Y Growth Projections, By Reagent – 2023 to 2033
Figure 113: MEA Market Attractiveness Index, By Reagent – 2023 to 2033
Figure 114: MEA Market Share, By Application – 2023 to 2033
Figure 115: MEA Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Figure 116: MEA Market Attractiveness Index, By Application – 2023 to 2033
Figure 117: MEA Market Share, By End User – 2023 to 2033
Figure 118: MEA Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Figure 119: MEA Market Attractiveness Index, By End User – 2023 to 2033
Figure 120: MEA Market Share, By Country – 2023 to 2033
Figure 121: MEA Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Figure 122: MEA Market Attractiveness Index, By Country – 2023 to 2033
Figure 123: Oceania Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2018 to 2033
Figure 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Figure 125: Oceania Market Share, By Modality – 2023 to 2033
Figure 126: Oceania Market Y-o-Y Growth Projections, By Modality – 2023 to 2033
Figure 127: Oceania Market Attractiveness Index, By Modality – 2023 to 2033
Figure 128: Oceania Market Share, By Reagent – 2023 to 2033
Figure 129: Oceania Market Y-o-Y Growth Projections, By Reagent – 2023 to 2033
Figure 130: Oceania Market Attractiveness Index, By Reagent – 2023 to 2033
Figure 131: Oceania Market Share, By Application – 2023 to 2033
Figure 132: Oceania Market Y-o-Y Growth Projections, By Application – 2023 to 2033
Figure 133: Oceania Market Attractiveness Index, By Application – 2023 to 2033
Figure 134: Oceania Market Share, By End User – 2023 to 2033
Figure 135: Oceania Market Y-o-Y Growth Projections, By End User – 2023 to 2033
Figure 136: Oceania Market Attractiveness Index, By End User – 2023 to 2033
Figure 137: Oceania Market Share, By Country – 2023 to 2033
Figure 138: Oceania Market Y-o-Y Growth Projections, By Country – 2023 to 2033
Figure 139: Oceania Market Attractiveness Index, By Country – 2023 to 2033
Figure 140: United States Market share by Modality, 2022
Figure 141: United States Market share by Reagent, 2022
Figure 142: United States Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 143: United States Market Share by End User, 2022
Figure 144: Canada Market share by Modality, 2022
Figure 145: Canada Market share by Reagent, 2022
Figure 146: Canada Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 147: Canada Market Share by End User, 2022
Figure 148: Germany Market share by Modality, 2022
Figure 149: Germany Market share by Reagent, 2022
Figure 150: Germany Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 151: Germany Market Share by End User, 2022
Figure 152: United Kingdom Market share by Modality, 2022
Figure 153: United Kingdom Market share by Reagent, 2022
Figure 154: United Kingdom Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 155: United Kingdom Market Share by End User, 2022
Figure 156: France Market share by Modality, 2022
Figure 157: France Market share by Reagent, 2022
Figure 158: France Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 159: France Market Share by End User, 2022
Figure 160: Russia Market share by Modality, 2022
Figure 161: Russia Market share by Reagent, 2022
Figure 162: Russia Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 163: Russia Market Share by End User, 2022
Figure 164: Spain Market share by Modality, 2022
Figure 165: Spain Market share by Reagent, 2022
Figure 166: Spain Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 167: Spain Market Share by End User, 2022
Figure 168: Italy Market share by Modality, 2022
Figure 169: Italy Market share by Reagent, 2022
Figure 170: Italy Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 171: Italy Market Share by End User, 2022
Figure 172: China Market share by Modality, 2022
Figure 173: China Market share by Reagent, 2022
Figure 174: China Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 175: China Market Share by End User, 2022
Figure 176: Japan Market share by Modality, 2022
Figure 177: Japan Market share by Reagent, 2022
Figure 178: Japan Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 179: Japan Market Share by End User, 2022
Figure 180: South Korea Market share by Modality, 2022
Figure 181: South Korea Market share by Reagent, 2022
Figure 182: South Korea Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 183: South Korea Market Share by End User, 2022
Figure 184: India Market share by Modality, 2022
Figure 185: India Market share by Reagent, 2022
Figure 186: India Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 187: India Market Share by End User, 2022
Figure 188: Singapore Market share by Modality, 2022
Figure 189: Singapore Market share by Reagent, 2022
Figure 190: Singapore Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 191: Singapore Market Share by End User, 2022
Figure 192: Indonesia Market share by Modality, 2022
Figure 193: Indonesia Market share by Reagent, 2022
Figure 194: Indonesia Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 195: Indonesia Market Share by End User, 2022
Figure 196: Thailand Market share by Modality, 2022
Figure 197: Thailand Market share by Reagent, 2022
Figure 198: Thailand Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 199: Thailand Market Share by End User, 2022
Figure 200: Brazil Market share by Modality, 2022
Figure 201: Brazil Market share by Reagent, 2022
Figure 202: Brazil Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 203: Brazil Market Share by End User, 2022
Figure 204: Mexico Market share by Modality, 2022
Figure 205: Mexico Market share by Reagent, 2022
Figure 206: Mexico Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 207: Mexico Market Share by End User, 2022
Figure 208: Turkey Market share by Modality, 2022
Figure 209: Turkey Market share by Reagent, 2022
Figure 210: Turkey Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 211: Turkey Market Share by End User, 2022
Figure 212: GCC Countries Market share by Modality, 2022
Figure 213: GCC Countries Market share by Reagent, 2022
Figure 214: GCC Countries Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 215: GCC Countries Market Share by End User, 2022
Figure 216: South Africa Market share by Modality, 2022
Figure 217: South Africa Market share by Reagent, 2022
Figure 218: South Africa Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 219: South Africa Market Share by End User, 2022
Figure 220: Australia Market share by Modality, 2022
Figure 221: Australia Market share by Reagent, 2022
Figure 222: Australia Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 223: Australia Market Share by End User, 2022
Figure 224: New Zealand Market share by Modality, 2022
Figure 225: New Zealand Market share by Reagent, 2022
Figure 226: New Zealand Market Value (US$ Mn) and Forecast 2023 to 2033
Figure 227: New Zealand Market Share by End User, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the market value for optical preclinical imaging in 2023?
The market for optical preclinical imaging is valued at US$ 612 million in 2023.
What is the predicted optical preclinical imaging market growth rate?
The global optical preclinical imaging market is expected to increase at a CAGR of 6.5% from 2023 to 2033.
What is the projected global market value for 2033?
Worldwide sales of optical preclinical imaging systems are predicted to reach US$ 1.14 billion by 2033.
What are the key trends in the optical preclinical imaging market report?
Market growth is being fueled by rising demand for non-invasive small animal imaging techniques and developing R&D infrastructure across the world.
Who are the key players in the optical preclinical imaging market?
BioTek Instruments, Inc., Bruker Corporation, and Fujifilm Holdings Corporation are leading providers of optical preclinical imaging technologies.
Optical Preclinical Imaging Market